Pazopanib Arm (n = 246) | |
---|---|
Age, y, mean (SD) | 54.0 (14.9) |
< 65 y, n (%) | 184 (75) |
≥65 y, n (%) | 62 (25) |
Female, n (%) | 147 (60) |
Weight, kg, mean (SD) | 71.5 (16.9) |
STS subtypes, n (%) | |
Leiomyosarcoma | 109 (44) |
Synovial sarcoma | 25 (10) |
Other STS histologies | 112 (46) |
Time since initial diagnosis, mo, median (IQR) | 26.6 (14.5–46.1) |
Time since last progression, mo, median (IQR) | 0.7 (0.3–1.1) |
Prior lines of therapy, n (%) | |
1 | 110 (45) |
2 or more | 136 (55) |